Skip to Content


Eli Y. Adashi and I. Glenn Cohen (Faculty Director)
JAMA
December 3, 2018

Read the full article

From the article:

Editing the genome of human gametes or embryos is a disruptive unactualized technology and continues to be the subject of a wide range of concerns. The chief concern is the safety and efficacy of such an intervention and the unintended errors that it might cause for future generations through the modified germline (ie, the gametes through which the genome is passed on to future generations). Additional concerns revolve around the equity of access to these innovative interventions. The benefits of heritable genome editing should not preferentially accrue only to affluent individuals. A separate set of objections, often framed in religious terms, focuses on the sanctity of human life, the dignity of procreation, the hubris of human intervention, and the usurpation of divine power. Additional concerns include the threat to disability rights (eg, deaf culture), the prospect of state-sanctioned eugenics, the cascading generational effects, and the rights of potential progeny whose consent can not be sought. Heritable genome editing has also been implicated in constraining genetic diversity while perpetuating conformity and homogeneity. The unforeseen costs of successful enhancement have also been raised as a potential concern.

Read more here!

Read the full article

Tags

bioethics   biotechnology   enhancement   genetics   health law policy   human subjects research   i. glenn cohen   regulation